RESUMEN
BACKGROUND: Sarcoptic mange is a serious animal welfare concern in bare-nosed wombats (Vombatus ursinus). Fluralaner (Bravecto®) is a novel acaricide that has recently been utilised for treating mange in wombats. The topical 'spot-on' formulation of fluralaner can limit treatment delivery options in situ, but dilution to a volume for 'pour-on' delivery is one practicable solution. This study investigated the in vitro acaricidal activity of Bravecto, a proposed essential oil-based diluent (Orange Power®), and two of its active constituents, limonene and citral, against Sarcoptes scabiei. METHODS: Sarcoptes scabiei were sourced from experimentally infested pigs. In vitro assays were performed to determine the lethal concentration (LC50) and survival time of the mites when exposed to varying concentrations of the test solutions. RESULTS: All compounds were highly effective at killing mites in vitro. The LC50 values of Bravecto, Orange Power, limonene and citral at 1 h were 14.61 mg/ml, 4.50%, 26.53% and 0.76%, respectively. The median survival times of mites exposed to undiluted Bravecto, Orange Power and their combination were 15, 5 and 10 min, respectively. A pilot survival assay of mites collected from a mange-affected wombat showed survival times of < 10 min when exposed to Bravecto and Orange Power and 20 min when exposed to moxidectin. CONCLUSIONS: These results confirm the acaricidal properties of Bravecto, demonstrate acaricidal properties of Orange Power and support the potential suitability of Orange Power and its active constituents as a diluent for Bravecto. As well as killing mites via direct exposure, Orange Power could potentially enhance the topical delivery of Bravecto to wombats by increasing drug penetration in hyperkeratotic crusts. Further research evaluating the physiochemical properties and modes of action of Orange Power and its constituents as a formulation vehicle would be of value.
Asunto(s)
Acaricidas , Isoxazoles , Aceites de Plantas , Sarcoptes scabiei , Escabiosis , Animales , Sarcoptes scabiei/efectos de los fármacos , Acaricidas/farmacología , Isoxazoles/farmacología , Escabiosis/tratamiento farmacológico , Escabiosis/parasitología , Aceites de Plantas/farmacología , Aceites de Plantas/química , Monoterpenos Acíclicos/farmacología , Porcinos , Limoneno/farmacología , Limoneno/química , Terpenos/farmacología , Terpenos/química , Ciclohexenos/farmacología , Ciclohexenos/química , Dosificación Letal MedianaRESUMEN
Lamydia pecorum is a globally recognised livestock pathogen that is capable of causing severe and economically significant diseases such as arthritis in sheep and cattle. Relatively little information is available on the clinical progression of disease and the long-term effects of asymptomatic and symptomatic chlamydiosis in sheep. Recent studies in calves indicate that endemic C. pecorum infections may reduce growth rates. To investigate the clinical health parameters and production impacts of endemic C. pecorum infection in an Australian commercial lamb flock, we performed bimonthly sampling and clinical health assessments on 105 Border Leicester lambs from two to ten months of age. Chlamydial status was investigated via serology and species-specific quantitative PCR. Throughout the study period, conjunctivitis remained a persistent clinical feature while signs of arthritis (e.g. palpable synovial joint effusions) resolved in a subset of lambs while persisting in others. Clinical disease and C. pecorum infection were highest at six months of age (weaning). As previously reported, peak seroconversion tends to occur two months after the onset of clinical symptoms (6 months of age), with lambs clearing chlamydial infection by 10 months of age, despite ongoing disease still being present at this time. Notably, the presence of chlamydial infection did not affect lamb mass or growth rates throughout the study. At necropsy, C. pecorum was not detected within the joints of lambs with chronic arthritis. Molecular analysis of the strains in this flock suggest that the infecting strains circulating in this flock are clonal C. pecorum pathotypes, denoted ST 23, commonly associated with conjunctivitis and polyarthritis in Australian sheep. This study provides a platform for further research in the epidemiology and disease transmission dynamics of C. pecorum infections in sheep.
Asunto(s)
Infecciones por Chlamydia/veterinaria , Chlamydia/aislamiento & purificación , Enfermedades Endémicas/veterinaria , Enfermedades de las Ovejas/epidemiología , Animales , Artritis/microbiología , Australia/epidemiología , Chlamydia/genética , Chlamydia/patogenicidad , Infecciones por Chlamydia/complicaciones , Infecciones por Chlamydia/microbiología , Infecciones por Chlamydia/fisiopatología , Conjuntivitis/microbiología , Granjas , Ganado/microbiología , Reacción en Cadena en Tiempo Real de la Polimerasa , Ovinos/microbiología , Enfermedades de las Ovejas/microbiología , Enfermedades de las Ovejas/transmisión , Oveja Doméstica/crecimiento & desarrollo , Oveja Doméstica/microbiología , Especificidad de la EspecieRESUMEN
The activity of QN50, a sequiterpene alcohol derived from Australian sandalwood (Santalum spicatum), was tested for its effectiveness against larvae of 2 mosquito species (Culex molestus and Aedes camptorhynchus [Diptera: Culicidael), nymphs of 2 species of water boatmen (Micronecta robusta and Agraptocorixa [Hemiptera: Corixidae]), immature Daphnia sp. (Crustacea), and mosquito eggs (Cx. molestus). In a series of laboratory bioassays, field-collected mosquito larvae, eggs, and immature corixids and daphnids were placed in beakers with either QN50, methoprene or source water only (control). The mosquito larvae exposed to QN50 had reduced survivorship and average longevity relative to the control and to methoprene at most concentrations used in this study. The hatching rate of mosquito eggs was unaffected by methoprene or QN50. Corixid nymphs and daphnids experienced high mortality in both methoprene and QN50 relative to the control, but there was no difference in the effect between the compounds. The results of this preliminary study suggest that further research into the mode of action and efficacy of QN50 as a potential alternative to methoprene for mosquito abatement is warranted.